The expansion was included in a rezoning request that was presented to council during its Sept. 12 meeting after the Coppell Planning and Zoning Commission recommended approval during its Aug. 17 meeting.
In a nutshell
AstraZeneca's facility is located at 508 Wrangler Drive on property zoned for light industrial use. A planned development request was necessary because the company is looking for a parking variance for a total of 200 spaces, a decrease from the current 237, according to a council memo.
The project will increase the facility’s number of manufacturing lines from six to eight and will be completed over two phases. The first phase includes the addition of a 19,893-square-foot structure housing a tank farm on the east side of the lot that will house chemicals used to manufacture AstraZeneca’s drug Lokelma.
The project’s second phase is a 3,000-square-foot addition in the rear of the existing structure on the lot. According to the memo, the expansion of the facility will allow AstraZeneca to meet the increasing demand for its drug used to medicate hyperkalemia, a condition that occurs if potassium levels are too high in a person’s bloodstream.
Quote of note
“Our goal is to meet the patients’ need for Lekoma, and the team is really dedicated to making sure we meet that demand,” AstraZeneca representative Jerome Doyle said.
In other news
Council approved a contract with Reliable Paving Inc. for over $4.8 million, funded by the 2020 bond, for the reconstruction of Woodhurst Drive.
A developer agreement between the city and Victory Retail Coppell LLC was also approved during the meeting, which lays out terms for the reimbursement for part of the reconstruction of South Belt Line Road. A change order of over $1.5 million was previously approved with Victory Retail Coppell covering nearly $344,467, about 25% of the cost.
Council also approved a fourth interlocal agreement with the Denton County Transportation Authority that will provide a first- and last-mile connectivity program to participating Coppell businesses. The program was presented during an Aug. 22 work session.
